ADAMTS7 and Hypertension: The percentage of ADAMTS7 promoter methylation did not differ in any subanalysis (diabetes vs. non-diabetes: 15.2% vs. 15.9, p = 0.722; hypertension vs. non-hypertension: 15.6% vs. 15.9%, p = 0.875; dyslipidemia vs. non-dyslipidemia: 17.1% vs. 14.1%, p = 0.080).